CARDIOLOGY

Clinical Mechanistic Insights Into Polymorphic Ventricular Tachycardia: Infection-Triggered Unmasking of Long QT Syndrome

Aug 8, 2026 by in CARDIOLOGY Comments Off on Clinical Mechanistic Insights Into Polymorphic Ventricular Tachycardia: Infection-Triggered Unmasking of Long QT Syndrome
A 63-year-old woman presented with fever, cough, and recurrent presyncope following a lower respiratory tract infection. Initial telemetry demonstrated intermittent complete atrioventricular block with ventricular premature complexes. Despite correction of…
read more

Outcomes of Patients With Mitral Stenosis With Prior Percutaneous Mitral Commissurotomy Undergoing Mitral Valve Surgery

Aug 8, 2026 by in CARDIOLOGY Comments Off on Outcomes of Patients With Mitral Stenosis With Prior Percutaneous Mitral Commissurotomy Undergoing Mitral Valve Surgery
Limited data exist on outcomes for patients with mitral stenosis (MS) who have previously undergone percutaneous mitral commissurotomy (PMC) and later require surgical mitral valve replacement (MVR). This study evaluates…
read more

AngioIMR—Trying to Assess Resistance With Ease

Aug 8, 2026 by in CARDIOLOGY Comments Off on AngioIMR—Trying to Assess Resistance With Ease
Coronary microvascular dysfunction (CMD), once relegated to the periphery of cardiovascular medicine, is now recognized as a major determinant of outcomes following ST-segment elevation myocardial infarction (STEMI). While epicardial reperfusion…
read more

Pregnancy Outcomes in Women With Cardiovascular Disease:A Retrospective Cohort Study from Kaiser Permanente Northern California

Aug 8, 2026 by in CARDIOLOGY Comments Off on Pregnancy Outcomes in Women With Cardiovascular Disease:A Retrospective Cohort Study from Kaiser Permanente Northern California
Cardiovascular disease (CVD) remains a leading cause of maternal mortality in the United States, comprising 26.5% of pregnancy-related deaths. We sought to evaluate trends in CVD during pregnancy and maternal,…
read more

Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients With Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial

Aug 8, 2026 by in CARDIOLOGY Comments Off on Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients With Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial
Heart failure (HF) with reduced ejection fraction (HFrEF) remains a major public health burden, affecting over 6 million adults in the United States. Despite advances in HF guideline-directed medical therapy…
read more
Get Clinical Tree app for offline access